v3.23.1
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net loss from continuing operations $ (19,178) $ (13,750)
Adjustments to reconcile net loss to net cash used in operating activities    
Non-cash write downs of inventory 797 1,073
Accretion expense 4,763 (1,337)
Depreciation of property and equipment and amortization of intangible assets 4,771 4,642
Amortization of operating right-of-use assets 454 487
Share-based compensation 1,713 3,356
Deferred income tax expense 1,446 (1,134)
Gain on fair value of warrants and purchase option derivative (438) (5,713)
Gain on disposal of fixed assets 307  
Revaluation of contingent consideration   119
Loss on derecognition of right of use assets 205  
Release of indemnification asset   (25)
Unrealized and realized foreign exchange (gain) loss (31) 356
Unrealized and realized loss on investments 699  
Changes in operating assets and liabilities    
Receivables 773 (2,656)
Inventory (4,969) 3,755
Prepaid expense and other current assets 1,203 985
Deposits 97 (593)
Other assets (131) 571
Accounts payable and accrued liabilities and other payables 6,882 (11,151)
Operating lease liability (473) (271)
Other liability (14) (437)
Contingent consideration payable   (324)
Corporate income tax payable 11,773 4,869
Deferred revenue (195) 395
Net cash (used in) / provided by operating activities- continuing operations 10,454 (16,783)
Net cash (used in) operating activities- discontinued operations (2,020) (2,064)
Net cash (used in) / provided by operating activities 8,434 (18,847)
Investing activities    
Investment in property and equipment (2,497) (3,812)
Investment in intangible assets (14) (106)
Principal payments received on lease receivable 111 156
Receipt of convertible debenture payment 738  
Deposits for property and equipment   (6,058)
Deposits for business acquisition   (602)
Payments made for land contracts (308)  
Cash portion of consideration paid in acquisitions, net of cash of acquired (9,611) 24,716
Net cash (used in) / provided by investing activities- continuing operations (11,581) 14,294
Net cash (used in) /provided by investing activities- discontinued operations   (381)
Net cash (used in) / provided by investing activities (11,581) 13,913
Financing activities    
Transfer of Employee Retention Credit 12,677  
Proceeds from options and warrants exercised 81 23,925
Loan principal paid (1,204)  
Capital contributions paid to non-controlling interests (1,884) (227)
Payments of contingent consideration   (6,630)
Payments made for financing obligations (157)  
Net cash provided by financing activities- continuing operations 9,513 17,068
Net cash provided by financing activities- discontinued operations (115)  
Net cash (used in) /provided by financing activities 9,398 17,068
Net increase in cash and cash equivalents and restricted cash during the period 6,251 12,134
Net effects of foreign exchange 523 (3,369)
Cash and cash equivalents and restricted cash, beginning of the period 26,763 79,642
Cash and cash equivalents and restricted cash, end of the period 33,537 88,407
Supplemental disclosure with respect to cash flows    
Income taxes (refund received) paid (551) 8
Interest paid 2,456 8,271
Lease termination fee paid   3,300
Non-cash transactions    
Equity and warrant liability issued as consideration for acquisition 750 294,800
Shares issued for liability settlement 593 22
Accrued capital purchases $ 555 $ 56

Source